In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Histogenics Corp.. Trade Record

NASDAQ:HSGX Histogenics Corp. stock gains 7.76% Exit Jul 27, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart HSGX Jul 12, 2017, priceSeries
About Histogenics Corp.

Histogenics Corporation, a regenerative medicine company, focuses on developing and commercializing products in the musculoskeletal segment of the marketplace. Its product candidate includes NeoCart, which is in Phase III clinical trials, intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. The company has an exclusive channel collaboration agreement with Intrexon Corporation for the development and commercialization of allogeneic genetically modified chondrocyte cell therapeutics for the treatment or repair of damaged articular hyaline cartilage in humans. Histogenics Corporation was founded in 2000 and is headquartered in Waltham, Massachusetts.

Trade Information
Trade Type
LONG
ReliabilityScore™
89.29
Entry Date
Jul 12, 2017
Entry Price
106.20
Sell Date
Jul 27, 2017
Sell Price
114.44
Net Gain
7.76%
Hold Time
11 Trading Days